Efficacy of Cognitive Stimulation Therapy Integrated With Stress Reduction Intervention for Adults With Mild Cognitive Impairment

ConditionMild Cognitive Impairment (MCI)

Trial statusNot yet recruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age45+

SponsorUniversity of the Punjab

About this trial

The aim of this study is to determine if integrating a culturally congruent indigenous stress reduction intervention into Cognitive Stimulation Therapy (CST) enhances cognitive outcomes in Pakistani adults with Mild Cognitive Impairment (MCI).

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adults aged 45 years and above

Individuals with education up to Matric

Individuals who obtain a score lower than 23 on Montreal Cognitive Assessment (MoCA) suggesting the presence of cognitive decline.

Individuals who obtain a score of 14 or more on the Perceived Stress Scale suggesting increased levels of perceived stress (moderate and high)

Disqualifiers

Diagnosis of dementia or major neurocognitive disorder

Presence of severe psychiatric illness (e.g., psychosis, major depressive episode)

Significant hearing or visual impairments that interfere with participation

Currently undergoing psychological or cognitive therapy

Trial design

Design model

Parallel

Treatments tested in this trial

Cognitive Stimulation Therapy integrated with Stress Reduction Intervention
Behavioral
Participants in this Arm will receive Cognitive Stimulation Therapy integrated with Stress Reduction Intervention for 7 weeks, combining structured cognitive exercises targeting memory, attention, and problem-solving with guided stress reduction techniques.
Cognitive Stimulation Therapy
Behavioral
Participants in this Arm will attend Cognitive Stimulation Therapy sessions only for 7 weeks, including structured cognitive exercises targeting memory, attention, and problem-solving in a group format.

Treatment groups

12 Participants

are divided into 3 treatment groups

Group A: Cognitive Stimulation Therapy integrated with Stress Reduction InterventionExperimental treatment 1 intervention

Group B: Cognitive Stimulation Therapy (CST)Active comparator 1 intervention

Group C: Control GroupNo intervention 0 interventions

Trial outcomes

Primary outcomes

Change in Montreal Cognitive Assessment (MoCA) total score from baseline to 7 weeks

The Montreal Cognitive Assessment (MoCA) will be used to assess overall cognitive functioning, including attention, memory, language, executive functions, and visuospatial abilities. The MoCA total score ranges from 0 to 30, with higher scores indicating better cognitive functioning. Assessments will be conducted at baseline and after completion of the 7-week intervention period.

Time frame

7 weeks

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of the Punjab

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: